Clinical Trials Directory

Trials / Unknown

UnknownNCT04669184

Sarcopenia and Physical Performance in Hemodialysis Patients

Assessment of Sarcopenia, Physical Performance and Cognitive Function in Hemodialysis Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
26 (estimated)
Sponsor
Hacettepe University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Many systems such as the cardiovascular, pulmonary, musculoskeletal, hematological, immunological, gastrointestinal, central nervous system are affected due to decreased kidney function. The aim of this study was to investigate the relationship between physical performance and sarcopenia, peripheral muscle strength, activities of daily living, cognitive functions, physical activity level, fragility, pain in hemodialysis patients.

Detailed description

A high prevalence of sarcopenia has been reported in end stage kidney disease. The incidence of sarcopenia increases with age. Muscle atrophy is caused by an imbalance between the anabolic and catabolic processes in chronic kidney disease. Sarcopenia and physical inactivity progress synergistically. Decreased physical performance is associated with sarcopenia. In hemodialysis patients, daily physical activity level and physical performance decrease. Cognitive impairment is common in chronic kidney disease. Uremic toxins can cause a decrease in cognitive function. One of the most important problems associated with hemodialysis is pain and pain negatively affects functional capacity and quality of life.

Conditions

Timeline

Start date
2021-01-01
Primary completion
2021-12-01
Completion
2022-03-01
First posted
2020-12-16
Last updated
2020-12-16

Source: ClinicalTrials.gov record NCT04669184. Inclusion in this directory is not an endorsement.